カタログ製品コード : C-EK11902
Human LDL Receptor/LDLR ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK11902
Human LDL Receptor/LDLR ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | LDL Receptor/LDLR | Human | 125.00 - 8000 pg/ml | 100 μl (prediluted) | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against LDLR |
Human LDLR Standard, lyophilized |
LDLR Detect Antibody |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
Washing Buffer (20×) |
Plate Covers |
■キーワード :
Homo sapiens,Human,Low-density lipoprotein receptor,LDL receptor,LDLR
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human LDLR. The Human LDL Receptor/LDLR ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Low-density lipoprotein (LDL) receptor (LDLR) is a mosaic protein of 839 amino acids which belongs to the LDLR gene family. It is a cell-surface receptor that recognizes the Apo B100, which is embedded in the outer phospholipid layer of LDL particles. The receptor also recognizes the Apo E protein found in chylomicron remnants and VLDL remnants.
LDLR mediates the endocytosis of cholesterol-rich LDL. LDLR complexes are present in clathrin-coated pits (or buds) on the cell surface, which when bound to LDL-cholesterol via adaptin, are pinched off to form clathrin-coated vesicles inside the cell. This allows LDL-cholesterol to be internalized in a process known as endocytosis and prevents the LDL just diffusing around the membrane surface. This occurs in all nucleated cells, but mainly in the liver which removes ~70% of LDL from the circulation. Hyperthyroidism may be associated with hypocholesterolaemia via upregulation of the LDLR, and hypothyroidism with the converse.